Corcept Therapeutics, Inc. (CORT)
32.18
+0.03
(+0.09%)
USD |
NASDAQ |
Mar 16, 16:00
32.19
+0.01
(+0.03%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 3.423B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Axsome Therapeutics, Inc. | 8.094B |
| Alphatec Holdings, Inc. | 1.907B |
| Harrow, Inc. | 1.300B |
| Ultragenyx Pharmaceutical, Inc. | 2.108B |
| Amneal Pharmaceuticals, Inc. | 3.757B |
Market Cap Related Metrics
| PE Ratio | 39.34 |
| PS Ratio | 5.067 |
| Price to Book Value | 5.284 |
| Price to Free Cash Flow | 27.21 |
| Price | 32.18 |
| Earnings Yield | 2.54% |
| Operating PE Ratio | 86.13 |
| Normalized PE Ratio | 39.34 |